CMAX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CMAX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
CareMax's change in receivables for the quarter that ended in Mar. 2024 was $7.1 Mil. It means CareMax's Accounts Receivable declined by $7.1 Mil from Dec. 2023 to Mar. 2024 .
CareMax's change in receivables for the fiscal year that ended in Dec. 2023 was $25.9 Mil. It means CareMax's Accounts Receivable declined by $25.9 Mil from Dec. 2022 to Dec. 2023 .
CareMax's Accounts Receivable for the quarter that ended in Mar. 2024 was $105.1 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CareMax's Days Sales Outstanding for the three months ended in Mar. 2024 was 41.31.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CareMax's liquidation value for the three months ended in Mar. 2024 was $-473.5 Mil.
The historical data trend for CareMax's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CareMax Annual Data | |||||||||
Trend | Dec20 | Dec21 | Dec22 | Dec23 | |||||
Change In Receivables | -4.21 | -3.84 | -66.56 | 25.94 |
CareMax Quarterly Data | ||||||||||||||||
Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Change In Receivables | Get a 7-Day Free Trial | -7.85 | 6.60 | 3.38 | 23.82 | 7.07 |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $40.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CareMax (NAS:CMAX) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
CareMax's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 105.148 | / | 232.246 | * | 91 |
= | 41.31 |
2. In Ben Graham's calculation of liquidation value, CareMax's accounts receivable are only considered to be worth 75% of book value:
CareMax's liquidation value for the quarter that ended in Mar. 2024 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 41.479 | - | 593.8 | + | 0.75 * 105.148 | + | 0.5 * 0 |
= | -473.5 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of CareMax's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Bryan Cho | director | 30 HUDSON YARDS, 72ND FLOOR, NEW YORK NY 10001 |
De La Torre Ralph | director, 10 percent owner | 4939 BROOKVIEW DRIVE, DALLAS TX 75220 |
Ryan Oquinn | director | 1000 NW 57 COURT, SUITE 400, MIAMI FL 33126 |
Kevin Berg | director | 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010 |
Beatriz Maria Assapimonwait | director | 1000 NW 57 CT., SUITE 400, MIAMI FL 33126 |
Vincent Omachonu | director | 1000 NW 57 CT., SUITE 400, MIAMI FL 33126 |
Jose Ramon Rodriguez | director | PRIMORIS SERVICES CORPORATION, 2300 NORTH FIELD STREET, SUITE 1900, DALLAS TX 75201 |
Related Cm Advisor, Llc | director | 30 HUDSON YARDS, 72ND FLOOR, NEW YORK NY 10001 |
Imc Holdings, Lp | 10 percent owner | 525 OKEECHOBEE BOULEVARD, SUITE 1050, WEST PALM BEACH FL 33401 |
William C. Lamoreaux | officer: EVP | 1000 NW 57 CT., SUITE 400, MIAMI FL 33126 |
Kevin Wirges | officer: EVP, Treasurer and CFO | 1000 NW 57 CT., SUITE 400, MIAMI FL 33126 |
De Solo Carlos A. | director, officer: President and CEO | 1000 NW 57 CT., SUITE 400, MIAMI FL 33126 |
Randy Simpson | director | C/O GLENVIEW CAPITAL MANAGEMENT, LLC, 767 FIFTH AVENUE, 44TH FLOOR, NEW YORK NY 10153 |
Solo Alberto De | officer: EVP and COO | 1000 NW 57 CT., SUITE 400, MIAMI FL 33126 |
Jennifer L. Carter | director | C/O DFP SPONSOR LLC, 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
From GuruFocus
By Business Wire • 10-25-2023
By GuruFocusNews GuruFocusNews • 07-07-2022
By Business Wire • 07-19-2023
By Business Wire Business Wire • 04-26-2023
By PRNewswire PRNewswire • 07-08-2022
By PRNewswire PRNewswire • 08-01-2022
By PRNewswire PRNewswire • 08-15-2022
By PRNewswire PRNewswire • 10-21-2022
By PRNewswire PRNewswire • 07-15-2022
By Business Wire • 09-06-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.